Anticoagulation and cataract surgery: a review of the current literature

Area of Science:

• Ophthalmology
• Anesthesiology
• Cardiology

Background:

• Anticoagulation with warfarin is vital for preventing systemic embolic events in patients with atrial fibrillation or prosthetic heart valves.
• Warfarin cessation and recommencement pose risks, including unpredictable anticoagulation reversal and dangerous hypercoagulable states.
• Managing anticoagulated patients undergoing cataract surgery presents significant challenges for both anesthesiologists and surgeons.

Purpose of the Study:

• To evaluate the risks and benefits of continuing anticoagulation during cataract surgery.
• To assess the safety and efficacy of different local anesthetic techniques in anticoagulated patients.
• To determine the incidence and outcomes of retrobulbar hemorrhage in this patient group.

Main Methods:

• Review of current evidence on warfarin therapy and cataract surgery.
• Analysis of local anesthetic techniques (e.g., deep eye blocks, sub-Tenon's, topical) in anticoagulated patients.
• Comparison of retrobulbar hemorrhage rates in anticoagulated versus non-anticoagulated patients.

Main Results:

• Continuing warfarin is essential for preventing devastating embolic complications in high-risk patients.
• Smaller needles and single injections with deep eye blocks, or sub-Tenon's and topical anesthesia, appear safer.
• Retrobulbar hemorrhage occurs more frequently in anticoagulated patients, whether anticoagulation is continued or ceased prior to surgery.

Conclusions:

• Careful consideration of anesthetic techniques is paramount for anticoagulated patients undergoing cataract surgery.
• Experienced surgeons can achieve good visual prognosis even in cases of retrobulbar hemorrhage.
• Balancing the risk of systemic embolism against the risk of local hemorrhage is critical.